admin - February 3, 2012
C-Reactive Protein screenings can help predict heart attack risk.
Recently, the Dr. Oz Show aired a groundbreaking show on Heart Disease in Women. One of the main elements of the show was a screening provided by Life Line Screening (and partners Northshore: Long Island Jewish Labs and Alere) for the entire studio audience. The test was for high-sensitivity C-Reactive Protein (hs-CRP), a new test that can help predict heart disease.
C-Reactive Protein provides a measure of inflammation in the body and can be done by a simple finger-stick.
As the show depicts, a normal artery is clear and blood flows through it smoothly. An artery with plaque may block blood a little bit but the blood still can still often flow. However, when the artery has plaque and also becomes inflamed, the blood can get blocked and this can lead to heart attack.
The segment is available on the Dr. Oz website at:
Life Line Screening was very pleased to provide this screening for the studio audience and urges all of our customers to watch this number one rated daytime show for important health information. Check www.doctoroz.com to learn when the show is airing in your area.